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Intravenous Leiomyomatosis with Inferior Vena Cava and Heart Ex-
tention: A Report of 6 Cases
Bao Liu, Sr., Changwei Liu, Sr.. Peking Union Medical College Hospital,
Beijing, China
Background: Intravenous Leiomyomatosis(IVL)is a rare, histological
benign but biological behavior malignant tumor. Literature reports on IVL
are less than 200 cases, and most majority of them are individual reports.
Methods: Six patients with intravenous leiomyomatosis involved in the
cava inferior vena were analyzed.
Results: Three patients received one-stage operation and two received
two-stage operation. All the operations were successful. No perioperative
death or other complications were observed. Among the six patients, pri-
mary tumor and intravenous tumor embolus were completely resected from
four patients. Residual tumor was remained in one patient who had serious
adherence due to multiple operations. However, with the anti-estrogen
therapy, the residual tumor had significantly regressed. All the patients had
tumor relapse after the operation.
Conclusion: We believe that IVL is group of disease and not a single
disease entity. Although IVL is extremely rare, vascular surgeon must pay
more attention to this disease. There are many therapeutic methods to
choose from when uterine leiomyomatosis involves the cava inferior vena,
amongwhich operation is the best choice. Anti-estrogen therapy seems to be
justified in patients with ER() and PR().
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Iliac Venous Stenting for Lower Extremity Venous Stasis Disease
Saadi Alhabouni, Anil Hingorani, Enrico Ascher, Natalie Marks, Alexander
Shiferson, Nirav Patel, Kapil ’Gopal, Theresa Jacob. Maimonides Medical
Center, Brooklyn, NY
Introduction: In a small subset of patient presenting with severe
venous stasis disease, we have been unable to identify the sources of reflux
with standard duplex imaging of the superficial, deep and perforating veins.
Recently we have been examining the iliac veins with IVUS and venography
to identify stenotic lesions.We herein review our finding with this technique.
Study Population: Patients with chronic venous stasis symptoms not
responding to conventional methods of treatment (leg elevation, compres-
sion stockings, Unna boots, radiofrequency ablation/stripping of varicose
veins/perforators/great saphenous vein). 54 patients were included, all of
which underwent iliac-femoral venography with assessment for stenosis. 24
(44.4%) patients had no detectable stenotic lesions are had no further
intervention. 30 (55.6%) patients had stenotic lesions and underwent vein
stenting. The stents spanned across the inguinal ligament in all but 3 patients
(90%).
Results: The venography-only group included 24 patients with an
average follow-up period of 4.5 months (range 1 week to 8 months). 11
(45.8%) had a CEAP of 6, only one of which (9.1%) healed their ulcers after
3 months.The vein stenting group included 30 patients with an average
follow-up period of 3.4 months (range 1 week-10 months). 22 (73.3%) had
a open ulcers, 11 (50%) of which healed their ulcers over a period of 1 week
to 8 months (average 3.25 months). (p0.02) (5.5%) patients developed
complications. Two developed stent thrombosis (one with a documented
hypercoagulable state, the other with a suspected hypercoagulable state).
Both were re-opened and re-stented. One patient developed a superficial
femoral artery pseudoaneurysm which was repaired with a stent graft. All
patient not needing postoperative anticoagulation were able to be stented on
an outpatient basis.
Conclusion: Many patients with lower extremity venous stasis symp-
toms have a component of iliac vein stenosis, and iliac vein stenting may
especially help patients with open ulcers. In contrast to pre-existing series,
only one-half of the patients were able to have lesions identified to be
stented. The procedure is relatively simple and safe, and can be performed on
an ambulatory basis.
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Lower Extremity Occlusive vs Non-occlusive DVT and the Risk of
Pulmonary Embolism
Saadi Alhabouni, Anil Hingorani, Enrico Ascher, Natalie Marks, Alexander
Shiferson, Nirav Patel, Kapil Gopal, Theresa Jacob. Maimonides Medical
Center, Brooklyn, NY
Introduction: Acute DVT has been appreciated as a risk factor for
pulmonary embolism (PE). However, it is not known whether having an
incomplete occlusion of the vein (AcuteNon-Occlusive-ANODVT) confers
a higher risk of PE when compared to completely occlusive thrombi (Acute
Occlusive-AO DVT). An incomplete occlusion indicates that there is some
flow of blood around the clot, and whether that flow could dislodge the clot.
Conversely, a completely occlusive clot may indicate a higher thrombus load
and thus confer a higher risk of PE.
Methods: We reviewed 2894 consecutive lower extremity venous
duplex studies performed for 2248 inpatients betweenNovember 2007-July
2008.All studies to evaluate for PE were noted.We divided the patients into
3 groups based on the location of their DVT: IVC/Iliac, Femoral-popliteal,
and Infra-popliteal DVTs. Analysis was done on two sets of data.The first set
included comparison of DVTs isolated to only one of the three anatomical
groups. The second set compared DVTs based on the location of the most
proximal clot.
Results: DVTs isolated to one anatomical group:In the IVC/Iliac
vein group, only one isolated AO DVT was found with no evidence of PE
(0%). Two ANO DVTs were identified with evidence of PE in one (50%).
(p0.667).In the Femoral-popliteal group, 31 isolated AO DVT were
found with evidence of PE in 6 patients (19.3%). 64 isolated ANO DVT
were found with evidence of PE in 8 patients (incidence of 12.5%).
(p0.374).In the Infra-popliteal group, 140 patients with isolated AO
DVT were identified with evidence of PE in 12 of them (incidence of
8.6%). 21 patients with isolated ANO DVT were identified with evidence
of PE in one (incidence of 4.8%). (p0.471)Analysis based on the most
proximal DVT:In the IVC/Iliac vein group, 41 AO DVT was found with
evidence of PE in four (9.75%). 30 ANO DVTs were identified with
evidence of PE in two of them (6.67%). (p0.496).In the Femoral-
popliteal group, 83 AO DVT were found with evidence of PE in 17
patients (20.5%). 125 ANO DVT were found with evidence of PE in 14
patients (11.2%) (p0.075).
Conclusion: There is no difference in the risk of pulmonary embolism
between acute occlusive and acute non-occlusive DVTs, and hence both
should be treated similarly.
Author Disclosures: S. Alhabouni, None; A. Hingorani, None; E.
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Treatment of Acute Iliofemoral Deep Vein Thrombosis: A Systematic
Review and Meta-analysis
Edward T. Casey1, M. Hassan Murad1, Mark Meissner2, Magaly Zumaeta
Garcia1, Mohamed B Elamin,1, Qian Shi1, Patricia J Erwin1, Victor M
Montori1, Peter Gloviczki1. 1Mayo Clinic, rochester, MN; 2University of
Washington, Seattle, WA
Objectives: To conduct a systematic review of the literature to identify
and summarize the best available evidence about the efficacy of the different
treatments for acute iliofemoral deep vein thrombosis (catheter-directed
thrombolysis, surgical thrombectomy and systemic anticoagulation).
Methods: Electronic databases (MEDLINE, EMBASE, Cochrane
CENTRAL, Web of Science, and SCOPUS) were searched with appropriate
terms through February 2008. Eligible studies were controlled trials (ran-
domized or non randomized) that enrolled participants with acute iliotibial
thrombosis. Relative risks (RR) were pooled from each study using random
effects model and I2 statistic was used to assess heterogeneity.
Results: Compared with systemic anti-coagulation, thrombectomy
was associated with a statistically significant reduction in the risk of devel-
oping postthrombotic syndrome (RR 0.67 (95% confidence interval [CI],
0.52-0.87; I20%) and venous reflux (RR 0.68; 95% CI, 0.46-0.99;
I243%), and a trend for reduction in the risk of venous obstruction (RR
0.84; 95% CI, 0.60-1.19; I266%). Compared with systemic anti-coagula-
tion, catheter-directed thrombolysis was associated with statistically signifi-
cant reduction in the risk of postthromotic syndrome (RR 0.19; 95% CI,
0.07-0.48; I264%), venous reflux (RR 0.21; 95% CI, 0.09-0.53; I20%)
and venous obstruction (RR 0.35; 95% CI, 0.17-0.34; I268%). Subgroup
analyses showed no significant interactions between effect size and the time
lapsed since symptoms onset or the proportion of patients lost to follow up.
The superiority of thrombectomy over anticoagulation was significant in
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follow up over a year. Patient important outcomes (death, pulmonary
embolism, quality of life) were poorly reported and their estimates were
imprecise. The quality of included studies was moderate to low.
Conclusions: Very low quality evidence suggests that surgical throm-
bectomy decreases the incidence of postthrombotic syndrome and increases
venous valve competency; catheter-directed thrombolysis increases venous
patency and valve competency. Additional rigorous research is required to
determine the relative superiority of these technologies and their impact on
patient-important outcomes.
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Incidence and Charateristics of Venous Thromboembolic Disease Dur-
ing Pregnancy: A Contemporary Series
David O’Connor, Larry A Scher, Nicholas J Gargiulo, III, Hemal Shah,
Williamq D Suggs, Evan C Lipsitz. Montefiore Medical Center, Bronx, NY
Objective: To evaluate the incidence and characteristics of venous
thromboembolic events (VTE) associated with pregnancy in a contemporary
patient series.
Method: We performed a retrospective review of 33,311 deliveries
between June, 2003 and June, 2008. Patients with objective documentation
of a VTE during pregnancy or the three month postnatal period were
identified from hospital discharge ICD-9 codes. Diagnosis of deep venous
thrombosis (DVT) was largely made by Duplex ultrasound and pulmonary
embolism (PE) by computerized tomographic angiography (CTA).
Results: Of 33,311 deliveries during the study period, 74 patients
(0.22%) had a VTE. There were 40 incidents of DVT (0.12%) and 37
incidents of PE (0.11%). DVT involved the iliac veins (6), the femoral or
popliteal veins (16), the infrapopliteal veins (17) and the axillary vein (1).
Most (57.5%) DVT involved the left lower extremity. Only five (6.8%) of
these 74 patients had a prior history of VTE. Thirty-eight (51.6%) of the
VTEs occurred in the postnatal period, 33 (87%) within one week of
delivery. Sixty-eight percent of the postnatal VTEs were in patients under-
going cesarean section. Among patients with VTE during pregnancy, there
were 28% in the first trimester, 25% in the second, and 47% in the third.
Events were distributed among maternal age groups as follows: 26% age13-
24, 50% age 25-34 and 24% age 35-54. Patients with a VTE during
pregnancy were treated with low molecular weight or unfractionated hepa-
rin. Most postnatal patients were treated with subcutaneous low molecular
weight heparin and coumadin. Six IVC filters were placed in patients with
bleeding complications from anticoagulation. There were no deaths.
Conclusions: Comparing our results to historic controls (DVT: 0.04-
0.14% and PE: 0.003-0.04%), the incidence of DVT in pregnancy has not
changed significantly. We note, however, that the incidence of pulmonary
embolus in our series is higher than previously reported. CTA has been
utilized for the diagnosis of PE for only the past decade. The increase in the
rate of PE in the current series may be due to the higher sensitivity of CTA
when compared with previous diagnostic modalities.
Author Disclosures: D. O’Connor, None; L.A. Scher, None; N.J. Gar-
giulo, None; H. Shah, None; W.D. Suggs, None; E.C. Lipsitz, None.
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Prediction of Major Adverse Cardiac Events in Vascular Surgery: Are
Cardiac Risk Scores of Any Practical Value?
Chetan D Parmar, Francesco Torella. University Hospital Aintree, Liver-
pool, Liverpool, United Kingdom
Objective: Disease-specific preoperative scoring systems are often used
to predict postoperative cardiac complications. We retrospectively evaluated
the accuracy of two cardiac risk scores in the prediction of major adverse
cardiac events after vascular surgery.
Methods: Consecutive elective reconstructive arterial surgery proce-
dures were “scored” according to the Revised Cardiac Risk Index and the
Eagle criteria. Two “generic” risk scoring systems, ASA grade and the
physiology Portsmouth POSSUM (P-POSSUM) score, were also docu-
mented for comparison. Statistical analysis was by Receiver Operator Char-
acteristic (ROC) curves.
Results: After 344 reconstructive arterial surgical procedures, eighteen
patients suffered a major adverse cardiac event (5.2%; 95%CI2.8-7.58 -
four fatal). The Revised Cardiac Risk Index (AUC (95%CI).68 (.57-.83),
P .009) and the Eagle criteria (AUC (95%CI).73 (.57-.8), P.001)were no better than P-POSSUM (AUC (95%CI).82 (.73-.91), P.001)
and ASA grade (AUC (95%CI).67 (.56-.78), P.016) in predicting major
adverse cardiac events. Age was as good as any scoring system, with an AUC
of .79 (.68-.89). Of the variables included in the two cardiac scoring systems,
only age and history of ischaemic heart disease were associated with major
adverse cardiac events in our patients.
Conclusion: Cardiac risk scores were no better than generic risk
scoring systems in predicting major adverse cardiac events. Poor perfor-
mance may be due to differences between our patient population and those
in which the scores were developed, and to improved perioperative manage-
ment of cardiac risk.
Author Disclosures: C.D. Parmar, None; F. Torella, None.
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Perioperative Asymptomatic Cardiac Damage after Endovascular Ab-
dominal Aneurysm Repair is Associated with Poor Long-term Out-
come
Olaf Schouten1, Tamara A Winkel1, Jan-Peter van Kuijk1, Hence J M
Verhagen1, Jeroen J Bax2, Don Poldermans1. 1Erasmus Medical Center
Rotterdam, Rotterdam, Netherlands; 2Leiden University Medical Center,
Leiden, Netherlands
Background:Endovascular abdominal aortic aneurysm (AAA) repair is
associated with a decreased incidence of perioperative cardiac complications
compared to open repair. However, endovascular AAA repair is not associ-
ated with long-term survival benefit. Intensified care during follow-upmight
improve prognosis.
Aim: To assess the impact of perioperative asymptomatic cardiac
damage after endovascular AAA repair on long-term prognosis.
Methods: In 228 patients undergoing elective endovascular AAA
repair routine sampling of cardiac troponin T (cTnT) and ECG recording
was performed on days 1, 3, 7, and at the day of discharge. Elevated cTnT
was defined as serum concentrations  0.01 ng/ml. Asymptomatic cardiac
damage was defined as cTnT release without symptoms and/or ECG
changes.The median follow-up was 2.9 years and survival status was ob-
tained by contacting the civil service registry.
Results: A total of 29/228 (12.7%) patients had cTnT release, median
0.08 ng/ml, of whom 24 (83%) were asymptomatic and without ECG
changes. Patients with asymptomatic cardiac damage had a higher mortality
rate after 2.9 years compared to those without perioperative cardiac damage
(56% vs 18%, p0.001, figure). Also after adjustment for risk factors and
medication use applying multivariate Cox regression analysis, asymptomatic
cardiac damage was associated with a 3.6 fold increased risk for mortality
(HR 3.6, 95% CI 1.8-7.1) while statin use was associated with a reduced risk
for long-term mortality (HR 0.58, 95% CI 0.3-0.9).
Conclusion: Asymptomatic cardiac damage in patients undergoing
endovascular AAA repair is associated with poor long-term outcome. Rou-
tine perioperative cardiac screening after endovascular AAA repair might be
warranted.
Author Disclosures: O. Schouten, None; T.A. Winkel, None; J. van
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None.
